Winslow J T, Insel T R, Trullas R, Skolnick P
Laboratory of Clinical Science, NIMH, ADAMHA, Poolesville, MD 20837.
Eur J Pharmacol. 1990 Nov 6;190(1-2):11-21. doi: 10.1016/0014-2999(90)94107-9.
Compounds that reduce ion flux through N-methyl-D-aspartate (NMDA) coupled cation channels were evaluated for their effects on rat pup ultrasonic vocalizations (USV). Previous studies have demonstrated that rat pups emit ultrasonic calls during social isolation and that several classes of anxiolytics decrease, while putative anxiogenics increase, the number of these calls. The competitive NMDA antagonists 2-amino-7-phosphonoheptanoic acid (AP-7) and (+/-)-3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid [+/-)-CPP) as well as a partial agonist at the strychnine-insensitive glycine receptor, 1-aminocyclopropanecarboxylic acid (ACPC), reduced USV at doses that did not affect either motor activity or core temperature. A dose of glycine sufficient to elevate hippocampal glycine concentrations by 85% antagonized the effects of ACPC, but not AP-7. Glycine alone did not alter USV, but NMDA when given by itself increased USV by almost 50% at subconvulsant doses. Moreover, a dose of NMDA that did not affect USV antagonized the effects of AP-7 but not ACPC. Taken together, these findings are consistent with previous studies using conflict procedures which indicate that agents which reduce activity at NMDA receptor coupled cation channels may constitute a new class of anxiolytic agents.
对能够减少通过N-甲基-D-天冬氨酸(NMDA)偶联阳离子通道的离子通量的化合物,评估了它们对幼鼠超声波发声(USV)的影响。先前的研究表明,幼鼠在社会隔离期间会发出超声波叫声,并且几类抗焦虑药会减少此类叫声的数量,而假定的致焦虑剂则会增加。竞争性NMDA拮抗剂2-氨基-7-膦酰庚酸(AP-7)和(±)-3-(2-羧基哌嗪-4-基)-丙基-1-膦酸[(±)-CPP],以及士的宁不敏感甘氨酸受体的部分激动剂1-氨基环丙烷羧酸(ACPC),在不影响运动活性或核心体温的剂量下可减少USV。足以使海马甘氨酸浓度升高85%的甘氨酸剂量可拮抗ACPC的作用,但不能拮抗AP-7的作用。单独的甘氨酸不会改变USV,但NMDA单独给药时,在亚惊厥剂量下可使USV增加近50%。此外,不影响USV的NMDA剂量可拮抗AP-7的作用,但不能拮抗ACPC的作用。综上所述,这些发现与先前使用冲突程序的研究一致,这些研究表明,降低NMDA受体偶联阳离子通道活性的药物可能构成一类新的抗焦虑药。